Understanding the Role of Daratumumab in Modern Cancer Therapy
Daratumumab, known commercially as Darzalex, marks a pivotal advancement in multiple myeloma treatment, offering new hope for patients with limited options. As the first FDA-approved monoclonal antibody for this condition, it enhances the immune system’s ability to target cancer cells. Explore its clinical efficacy, administration methods, and transformative impact on modern cancer therapy. Understanding Daratumumab […]
3 minute read